Portage Biotech (PRTG)
(Delayed Data from NSDQ)
$8.72 USD
-1.49 (-14.59%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.56 -0.16 (-1.83%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.72 USD
-1.49 (-14.59%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.56 -0.16 (-1.83%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
New Strong Buy Stocks for January 26th
by Zacks Equity Research
FYBR, SPPJY, KMTUY, PRTG and ASML have been added to the Zacks Rank #1 (Strong Buy) List on January 26, 2023.
Best Momentum Stocks to Buy for January 20th
by Zacks Equity Research
NBSE, PRTG and NOMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 20, 2022.
New Strong Buy Stocks for January 20th
by Zacks Equity Research
NBSE, PRTG, RELL, HOWL and PATH have been added to the Zacks Rank #1 (Strong Buy) List on January 20, 2022.
How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 160%
by Zacks Equity Research
The consensus price target hints at a 159.8% upside potential for Portage Biotech Inc. (PRTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
New Strong Buy Stocks for November 1st
by Zacks Equity Research
FFNW, PTEN, PRTG, NTNX and GAMB have been added to the Zacks Rank #1 (Strong Buy) List on November 1, 2022.
Bears are Losing Control Over Portage Biotech Inc. (PRTG), Here's Why It's a 'Buy' Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Portage Biotech Inc. (PRTG), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
How Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 268%
by Zacks Equity Research
The consensus price target hints at a 268.4% upside potential for Portage Biotech Inc. (PRTG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Does Portage Biotech Inc. (PRTG) Have the Potential to Rally 206% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Portage Biotech Inc. (PRTG) points to a 206.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.